Use to assess cardiovascular disease risk and guide therapy.
Quantitative Detergent Solubilization/ Enzymatic
Sun-Sat
Within 24 hours
Plasma separator tube or serum separator tube. Also acceptable: Green (sodium or lithium heparin), lavender (EDTA), or pink (K2EDTA).
Allow specimen to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Refrigerated.
After separation from cells: Ambient: 8 hours; Refrigerated: 5 days; Frozen: 1 month
Age |
Desirable |
Borderline |
Higher Risk |
---|---|---|---|
0-19 years | 109 mg/dL or less | 110-129 mg/dL | 130 mg/dL or greater |
20 years and older | 129 mg/dL or less (99 mg/dL or less if patient has CHD) | 130-159 mg/dL | 160 mg/dL or greater |
CHD Risk Factors:
+1 Age: Men, 45 years and older
Women, 55 years and older or premature menopause without estrogen therapy
+1 Family history of premature CHD
+1 Current smoking
+1 Hypertension
+1 Diabetes mellitus
+1 Low HDL Cholesterol: 39 mg/dL or less
-1 High HDL Cholesterol: 60 mg/dL or greater
LDL Cholesterol: Therapeutic goal
99 mg/dL or less if CHD is present (Optional 69 mg/dL or less).
129 mg/dL or less if no CHD and two or more risk factors.
159 mg/dL or less if no CHD.
(Circulation 2004; 110:227-39)
FDA
83721
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0020257 | LDL Cholesterol, Direct | 18262-6 |
- Direct LDL
- LDL
- Low Density Lipoprotein